Cargando…
Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical center
OBJECTIVE: Research biopsies are an essential component of cancer clinical trials for studying drug efficacy and identifying biomarkers. Site-level clinical investigators, however, do not have access to results on the adequacy of research biopsies for histological or molecular assays, because sample...
Autores principales: | Lee, Kyoungmin, Lee, So Jung, Yoon, Shinkyo, Ryoo, Baek-Yeol, Kim, Sang-We, Choi, Sang Hyun, Lee, Sang Min, Chae, Eun Jin, Park, Yangsoon, Jang, Se-Jin, Park, Soo-Yeon, Yoon, Young-Kwang, Park, Seong Ho, Kim, Tae Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690517/ https://www.ncbi.nlm.nih.gov/pubmed/31404103 http://dx.doi.org/10.1371/journal.pone.0221065 |
Ejemplares similares
-
Real‐world utility of next‐generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinoma
por: Kim, Jwa Hoon, et al.
Publicado: (2021) -
Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer
por: Cho, Su Han, et al.
Publicado: (2021) -
Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteria
por: Roh, Yun Hwa, et al.
Publicado: (2023) -
Clinical significance of MET gene amplification in metastatic or locally advanced gastric cancer treated with first-line fluoropyrimidine and platinum combination chemotherapy
por: Seo, Seyoung, et al.
Publicado: (2019) -
Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus Cisplatin
por: Jeong, Hyehyun, et al.
Publicado: (2021)